Discover how today's tariff challenges could reshape the future of manufacturing and the pharmaceutical industry. In this insightful Q&A, Marcel Botha, CEO of 10XBeta, breaks down the risks companies face, from supply chain disruptions to rising costs, while also highlighting the exciting opportunities to drive innovation and bring cutting-edge manufacturing back to the U.S. If you want to understand the real impact of tariffs and why now could be a turning point for American industry, this article is a must-read.
Read the full Q&A article.
About
Pharmaceutical Executive
Pharmaceutical Executive® provides insights and stories behind successful commercial strategies, research and development (R&D), market access and more, to its audience of pharmaceutical executives. Our original print and digital content is produced by a team of fulltime, in-house writers and industry experts, which makes us stand out from the competition. We go beyond the 24-hour news cycle and provide in-depth analysis and the strategic context to help executives navigate the maze of policy and business challenges that face this changing industry.
ABOUT THE Author
Mike Hollan
Mike Hollan is an assistant managing editor for Pharmaceutical Executive and Medical Device and Technology.
